CoChat

Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy

Open access
Kohn, Taylor P., Louis, Matthew R., Pickett, Stephen M., Lindgren, Mark C., Kohn, Jaden R., Pastuszak, Alexander W., Lipshultz, Larry I. · 2017 · Fertility and Sterility
Cited by 67

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Objective To determine factors that influence sperm recovery after testosterone-associated infertility. Design Clinical retrospective study. Setting Academic male-infertility urology clinic. Patient(s) Sixty-six men who presented with infertility after testosterone use. Intervention(s) Testosterone (T) cessation and combination high-dose human chorionic gonadotropin (hCG) and selective estrogen modulator (SERM) therapy. Main Outcome Measure(s) Whether patients successfully achieved or failed to achieve a total motile count (TMC) of greater than 5 million sperm within 12 months of T cessation and initiation of therapy. Result(s) A TMC of greater than 5 million sperm was achieved by 46 men (70%). Both increased age and duration of testosterone use directly correlated with time to sperm recovery at both 6 and 12 months of hCG/SERM therapy. Age more consistently limited sperm recovery, while duration of testosterone use had less influence at 12 months than at 6 months. Only 64.8% of azoospermic men achieved a TMC greater than 5 million sperm at 12 months, compared with 91.7% of cryptozoospermic men, yet this did not predict a failure of sperm recovery. Conclusion(s) Increasing age and duration of testosterone use significantly reduce the likelihood of recovery of sperm in the ejaculate, based on a criterion of a TMC of 5 million sperm, at 6 and 12 months. Physicians should be cautious in pursuing long-term testosterone therapy, particularly in men who still desire fertility. Using these findings, physicians can counsel men regarding the likelihood of recovery of sperm at 6 and 12 months.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.fertnstert.2016.10.004

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 18

  1. McKinlay, 2007, Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey, Eur Urol, 52, 389, 10.1016/j.eururo.2007.03.013 · DOI
  2. Nguyen, 2015, Testosterone and “age-related hypogonadism”—FDA concerns, N Eng J Med, 373, 689, 10.1056/NEJMp1506632 · DOI · Paper page
  3. Layton, 2014, Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011, J Clin Endocrinol Metab, 99, 835, 10.1210/jc.2013-3570 · DOI · Paper page
  4. Kolettis, 2015, Medical testosterone: an iatrogenic cause of male infertility and a growing problem, Urology, 85, 1068, 10.1016/j.urology.2014.12.052 · DOI
  5. Ko, 2012, Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association, J Urol, 187, 973, 10.1016/j.juro.2011.10.137 · DOI · Paper page
  6. McBride, 2016, Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use, Asian J Androl, 18, 373, 10.4103/1008-682X.173938 · DOI
  7. Ly, 2005, Rates of suppression and recovery of human sperm output in testosterone-based hormonal contraceptive regimens, Hum Reprod, 20, 1733, 10.1093/humrep/deh834 · DOI · Paper page
  8. Menon, 2003, Successful treatment of anabolic steroid-induced azoospermia with human chorionic gonadotropin and human menopausal gonadotropin, Fertil Steril, 79, 1659, 10.1016/S0015-0282(03)00365-0 · DOI
  9. Liu, 1999, Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men, Hum Reprod, 14, 1540, 10.1093/humrep/14.6.1540 · DOI · Paper page
  10. Coward, 2014, Vasectomy reversal outcomes in men previously on testosterone supplementation therapy, Urology, 84, 1335, 10.1016/j.urology.2014.06.081 · DOI
  11. Rahnema, 2014, Anabolic steroid-induced hypogonadism: diagnosis and treatment, Fertil Steril, 101, 1271, 10.1016/j.fertnstert.2014.02.002 · DOI · Paper page
  12. Ishikawa, 2007, Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism, Fertil Steril, 88, 1697, 10.1016/j.fertnstert.2006.11.022 · DOI
  13. Gill, 1998, Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin, Postgrad Med J, 74, 45, 10.1136/pgmj.74.867.45 · DOI
  14. Hay, 2005, A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception, J Clin Endocrinol Metab, 90, 2042, 10.1210/jc.2004-0895 · DOI · Paper page
  15. Kinniburgh, 2002, Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men, Hum Reprod, 17, 1490, 10.1093/humrep/17.6.1490 · DOI · Paper page
  16. Amory, 2001, Daily testosterone and gonadotropin levels are similar in azoospermic and nonazoospermic normal men administered weekly testosterone: implications for male contraceptive development, J Androl, 22, 1053, 10.1002/j.1939-4640.2001.tb03445.x · DOI · Paper page
  17. Turner, 2003, Contraceptive efficacy of a depot progestin and androgen combination in men, J Clin Endocrinol Metab, 88, 4659, 10.1210/jc.2003-030107 · DOI · Paper page
  18. World Health Organization Task Force on Methods for the Regulations of Male Fertility, 1995, Rates of testosterone-induced suppression to severe oligozoospermia or azoospermia in two multinational clinical studies, Int J Androl, 18, 157, 10.1111/j.1365-2605.1995.tb00405.x · DOI

Cited by

Metadata

Authors
Kohn, T. P., Louis, M. R., Pickett, S. M., Lindgren, M. C., Kohn, J. R., Pastuszak, A. W., & Lipshultz, L. I.
Venue
Fertility and Sterility
Publisher
Elsevier BV
Published
2017-02
Volume
107
Issue
2
Pages
351-357.e1
ISSN
0015-0282 (ISSN-L)
OpenAlex
W2556419258
Cited by
67
References
6
FWCI
7.49
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.